Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial
Sign Up to like & getrecommendations! Published in 2021 at "Critical Care"
DOI: 10.1186/s13054-021-03842-9
Abstract: While targeted temperature management (TTM) has been recommended in patients with shockable cardiac arrest (CA) and suggested in patients with non-shockable rhythms, few data exist regarding the impact of the rewarming rate on systemic inflammation.… read more here.
Keywords: rewarming rate; arrest; cardiac arrest; patients shockable ... See more keywords